Inhibrx - Stock Price History | INBX
Historical daily share price chart and data for Inhibrx since 2022 adjusted for splits. The latest closing stock price for Inhibrx as of May 27, 2022 is 13.65.
- The all-time high Inhibrx stock closing price was 50.00 on December 17, 2020.
- The Inhibrx 52-week high stock price is 47.90, which is 250.9% above the current share price.
- The Inhibrx 52-week low stock price is 11.56, which is 15.3% below the current share price.
- The average Inhibrx stock price for the last 52 weeks is 29.00.
| Inhibrx Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2021 | 30.1584 | 31.2600 | 46.0200 | 14.6900 | 43.6700 | 32.45% |
| 2020 | 23.9004 | 20.6300 | 50.0000 | 15.9600 | 32.9700 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Biomedical and Genetics | $0.533B | $0.007B |
| Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bristol Myers Squibb (BMY) | United States | $162.107B | 9.86 |
| Bio-Rad Laboratories (BIO.B) | United States | $15.121B | 32.79 |
| QIAGEN (QGEN) | Netherlands | $10.761B | 16.99 |
| Biohaven Pharmaceutical Holding (BHVN) | United States | $10.111B | 0.00 |
| Ginkgo Bioworks Holdings (DNA) | United States | $5.648B | 0.00 |
| Emergent Biosolutions (EBS) | United States | $1.770B | 7.57 |
| Arcus Biosciences (RCUS) | United States | $1.376B | 34.89 |
| Myovant Sciences (MYOV) | United Kingdom | $1.033B | 0.00 |
| Zymeworks (ZYME) | Canada | $0.397B | 0.00 |
| Gelesis Holdings (GLS) | United States | $0.345B | 0.00 |
| Ambrx Biopharma (AMAM) | United States | $0.157B | 0.00 |
| Enzo Biochem (ENZ) | United States | $0.110B | 22.60 |
| SQZ Biotechnologies (SQZ) | United States | $0.100B | 0.00 |
| ADC Therapeutics SA (ADCT) | Switzerland | $0.000B | 0.00 |
